TIA1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.964200E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.632400E-02
Normal-vs-Stage2
7.824000E-04
Normal-vs-Stage3
4.003700E-02
Normal-vs-Stage4
1.622190E-01
Stage1-vs-Stage2
8.428200E-01
Stage1-vs-Stage3
1.308380E-01
Stage1-vs-Stage4
8.041000E-01
Stage2-vs-Stage3
1.298040E-01
Stage2-vs-Stage4
6.501000E-01
Stage3-vs-Stage4
1.748960E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.776600E-04
Normal-vs-AfricanAmerican
6.655600E-02
Normal-vs-Asian
2.486400E-02
Caucasian-vs-AfricanAmerican
6.616800E-01
Caucasian-vs-Asian
6.090000E-01
AfricanAmerican-vs-Asian
9.704800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.984950E-01
Normal-vs-Female
3.863400E-03
Male-vs-Female
8.316200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.323050E-01
Normal-vs-Age(41-60Yrs)
2.286400E-01
Normal-vs-Age(61-80Yrs)
1.878410E-03
Normal-vs-Age(81-100Yrs)
6.700700E-03
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.654200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.830000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.305600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.607420E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.480790E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.978600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.818980E-01
Normal-vs-Daily Drinker
6.383200E-03
Normal-vs-Weekly Drinker
4.276700E-03
Normal-vs-Occasional Drinker
7.338500E-02
Normal-vs-Social Drinker
2.021600E-02
Non Drinker-vs-Daily Drinker
9.866600E-01
Non Drinker-vs-Weekly Drinker
6.835800E-01
Non Drinker-vs-Occasional Drinker
1.806210E-01
Non Drinker-vs-Social Drinker
1.668630E-01
Daily Drinker-vs-Weekly Drinker
7.330000E-01
Daily Drinker-vs-Occasional Drinker
2.153200E-01
Daily Drinker-vs-Social Drinker
2.680400E-01
Weekly Drinker-vs-Occasional Drinker
1.592810E-01
Weekly Drinker-vs-Social Drinker
1.464770E-01
Occasional Drinker-vs-Social Drinker
8.112800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.167780E-01
Normal-vs-Grade 2
1.128270E-02
Normal-vs-Grade 3
1.138470E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.138600E-01
Grade 1-vs-Grade 3
2.070600E-01
Grade 1-vs-Grade 4
1.167780E-01
Grade 2-vs-Grade 3
4.847000E-01
Grade 2-vs-Grade 4
1.128270E-02
Grade 3-vs-Grade 4
1.138470E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.708600E-01
Normal-vs-NonDiabetic
1.677670E-03
Diabetic-vs-NonDiabetic
2.001400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.016010E-02
Normal-vs-NoPancreatitis
5.163400E-04
Pancreatitis-vs-NoPancreatitis
9.542000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.902800E-03
Normal-vs-N1
6.784100E-04
N0-vs-N1
9.458400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.478200E-01
Normal-vs-TP53-NonMutant
2.092600E-01
TP53-Mutant-vs-TP53-NonMutant
3.137600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
